• General Information

• Study Information

• Publications

• Participating Clinics

• Reference Materials

   History and Purpose

Advancing the field of closed-loop artificial pancreas research requires expert diabetologists partnering with expert mathematicians and engineers. Consortium investigators include leading endocrinologists and control theorists at top research institutions in the US and in Europe. Many of the leading diabetes device manufacturers have also participated, providing pumps and sensors with enhanced capabilities that allow for closed-loop experiments to be performed.

Consortium activities are coordinated by the Jaeb Center for Health Research, an organization with a strong track record of conducting high-impact, diabetes-related human clinical trials.  Regulatory affairs are streamlined by an advisory group of experienced JDRF personnel and outside consultants, ensuring good coordination with the Food and Drug Administration and other regulatory bodies. JDRF and FDA have partnered to proactively address regulatory obstacles, and in March 2006 the FDA named the artificial pancreas one of its Critical Path initiatives.